|Articles|January 29, 2015

Pharma 2015: Industry in Flux

Pharma is still a 21st Century growth industry, but investment dynamics no longer favor organic growth. Check out our strategic outlook infographic.

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!

Related Content

Rathi Suresh, PhD, Vice President, Analytics, Komodo Health.

The AI Force Multiplier: How AI Is Leveling the Playing Field for Small and Mid-Size Biotech

ByRathi Suresh, PhD

February 5th 2026

Taking Advantage of ‘Hidden Gem’ Talent Hubs

ByBjorn Reynolds

January 30th 2026

Lessons Learned From a Commercial Launch: Q&A with Greg Skalicky

ByMike Hollan

January 29th 2026

Bringing a Breakthrough Rare Disease Product to Patients: Q&A with Helen Sabzevari

ByMike Hollan

January 28th 2026

To Build or to Buy: Determining Your AI Path

ByRathi Suresh, PhD

January 20th 2026

Pharma 2015: Industry in Flux

Newsletter

Related Content

The AI Force Multiplier: How AI Is Leveling the Playing Field for Small and Mid-Size Biotech

Taking Advantage of ‘Hidden Gem’ Talent Hubs

Lessons Learned From a Commercial Launch: Q&A with Greg Skalicky

Bringing a Breakthrough Rare Disease Product to Patients: Q&A with Helen Sabzevari

To Build or to Buy: Determining Your AI Path

Trending on PharmExec

FDA to Take Action Against Mass-Marketing of Illegal Copycat Drugs: Report

Everything to Know About TrumpRx in 2026

Novo Nordisk Launches First Super Bowl Commercial for Wegovy Pill

Pharmaceutical Executive Daily: The Launch of TrumpRx